A case study on cravings and a GLP-1A case study on cravings and a GLP-1
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. As a reminder, STAT’s Isabella Cueto and J. Emory Parker are keeping track of every promise made by health secretary Robert F. Kennedy Jr. about reworking American health care. They just updated their tracker with Read More
Breast Cancer and Birth Control: A Huge New Study Shows How Science Can Be DistortedBreast Cancer and Birth Control: A Huge New Study Shows How Science Can Be Distorted
The study sought to answer questions about how breast cancer risk differs by type of hormonal contraceptive. Doctors say the results won’t change how they counsel patients.
Amazon scorpion venom shows stunning power against breast cancerAmazon scorpion venom shows stunning power against breast cancer
Scientists are turning venom, radioisotopes, engineered proteins, and AI into powerful new tools against cancer. From Amazonian scorpions yielding molecules that kill breast cancer cells as effectively as chemotherapy, to improved fibrin sealants and custom-grown bioactive factors, researchers are pushing biotechnology into uncharted territory. Parallel teams are advancing radiotheranostics that diagnose and destroy tumors with precision, while others forge experimental vaccines that train the immune system using hybrid dendritic cells.
Breast cancer treatments can improve both survival chances and incomeBreast cancer treatments can improve both survival chances and income
Radiation therapy treatment for breast cancer not only improves survival rates but also generates long-term financial benefits, according to a new study from the University of Copenhagen.
Novo Nordisk selling low doses of Ozempic, and Wegovy for $199 for a limited timeNovo Nordisk selling low doses of Ozempic, and Wegovy for $199 for a limited time
Novo Nordisk is now offering people who pay out of pocket a steep discount for select doses of Ozempic and Wegovy. Novo Nordisk is now offering people who pay out of pocket a steep discount for select doses of Ozempic and Wegovy.
Drugmaker Cuts Wegovy Price, but Doctors Still See Cost Challenges for PatientsDrugmaker Cuts Wegovy Price, but Doctors Still See Cost Challenges for Patients
(MedPage Today) — Novo Nordisk is chopping prices again for semaglutide (Wegovy), but doctors say the expense will remain challenging for patients without insurance. The drugmaker said Monday that it has started selling higher doses of the injectable… (MedPage Today) — Novo Nordisk is chopping prices again for semaglutide (Wegovy), but doctors say the Read More
Why Biomarker-Guided Radiotherapy in Breast Cancer Isn’t Ready for Prime TimeWhy Biomarker-Guided Radiotherapy in Breast Cancer Isn’t Ready for Prime Time
(MedPage Today) — A narrative review published earlier this year in JAMA Oncology highlighted a major gap in breast cancer care: While genomic tools guide systemic therapy, no clinically validated biomarker yet exists to inform radiotherapy decisions…
Tirzepatide may only temporarily suppress brain ‘food noise’ activityTirzepatide may only temporarily suppress brain ‘food noise’ activity
A rare glimpse into the brain activity of a patient with obesity and loss of control eating on tirzepatide, marketed as Mounjaro and Zepbound, revealed that the medication suppresses signaling in the brain’s “reward center” thought to be involved in food noise—but only temporarily. A rare glimpse into the brain activity of a patient with Read More
Single-dose radiation before surgery can eradicate breast cancerSingle-dose radiation before surgery can eradicate breast cancer
A single, targeted high dose of radiation delivered before other treatments could completely eradicate tumors in most women with early-stage, operable hormone-positive breast cancer, according to a study led by UT Southwestern Medical Center researchers. The findings, published in JAMA Network Open, could shift the paradigm for patients with the most common form of breast cancer, who typically undergo surgery before a regimen of radiation therapy.
Precision therapy could stop breast cancer at the sourcePrecision therapy could stop breast cancer at the source
Researchers at the University of California San Diego School of Medicine have identified a promising new therapy for triple-negative breast cancer (TNBC), which is among the most aggressive and difficult-to-treat forms of the disease.